Healthcare Press

US FDA approves Celgene's rare blood disorder drug

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 22 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 66%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

REUTERS: The U.S. Food and Drug Administration said on Friday it had approved Celgene Corp's treatment for a rare blood disorder. The drug, ...

REUTERS: The U.S. Food and Drug Administration said on Friday it had approved Celgene Corp's treatment for a rare blood disorder.

The drug, Reblozyl, is meant to treat anemia in patients with beta thalassemia who require regular red blood cell transfusions.Beta thalassemia is an inherited disorder that reduces the production of hemoglobin in blood, which can lead to lack of oxygen in many parts of the body and anemia, the FDA said.

Celgene is in the process of being bought by Bristol-Myers Squibb Co, under a deal announced earlier this year.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

US laboratory identifies rare new HIV strainWASHINGTON: A US healthcare company has identified a new subtype of the human immunodeficiency virus (HIV), and said the finding showed that ... 100%
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

US laboratory identifies rare new HIV strainWASHINGTON: A US healthcare company has identified a new subtype of the human immunodeficiency virus (HIV), and said the finding showed that ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »